Loading clinical trials...
Loading clinical trials...
Multicenter, Randomized, Double-blind, Parallel-group, Placebo Controlled, Study to Evaluate the Effects of Melatonin (Somnage®- Food Supplement) in the Management on Sleep Quality and Mood Alteration in Cancer Patients
Conditions
Interventions
Somnage
Placebo
Locations
5
Italy
Istituto Nazionale dei Tumori di Milano
Milan, Italy
I.E.O. Istituto Europeo di Oncologia
Milan, Italy
Azienda Ospedaliera S. Gerardo di Monza
Monza, Italy
Policlinico S. Matteo di Pavia
Pavia, Italy
Azienda di Servizi alla Persona di Pavia
Pavia, Italy
Start Date
October 1, 2015
Primary Completion Date
February 1, 2018
Completion Date
February 1, 2018
Last Updated
February 22, 2019
NCT07485114
NCT07336732
NCT05198830
NCT06305754
NCT07486219
NCT07190248
Lead Sponsor
Helsinn Healthcare SA
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions